HR 7085 United States House · 118th Congress

BIOSECURE Act

This bill prohibits U.S. government agencies from contracting with or purchasing biotechnology equipment/services from specific Chinese companies deemed national security threats, including BGI, MGI, Complete Genomics, and WuXi Apptec. It directly affects U.S. federal agencies (for procurement decisions), these Chinese biotech firms (for U.S. market access), and their U.S. contractors using their equipment. Key provisions establish a formal list of "biotechnology companies of concern" and ban government use of their equipment/services, with limited waivers allowed for national security needs. The law focuses on preventing U.S. genetic data collection via these firms, which the government asserts could be accessed by Chinese authorities under Chinese law.
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2024
Committee Review
Floor Vote
President
Introduced Jan 25, 2024 Last action Jan 25, 2024
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Jan 25, 2024
Committee
Referred to the House Committee on Oversight and Accountability.
lower
Jan 25, 2024
Introduced
Introduced in House
lower
1 primary · 10 co-sponsors

Sponsors